Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4876
Innoviz Technologies
INVZ
$108M
| $5.52K | ﹤0.01% |
6,467
-253,500
| -98% | -$401K |
2025 Q2
2 quarters
|
|
4877
Dorchester Minerals
DMLP
$1.41B
| $5.34K | ﹤0.01% |
+239
| New | +$5.59K |
2025 Q4
0 quarters
|
|
4878
Innovator US Equity Power Buffer ETF October
POCT
$959M
| $5.23K | ﹤0.01% |
+119
| New | +$5.17K |
2025 Q4
0 quarters
|
|
4879
Vermilion Energy
VET
$1.78B
| $5.12K | ﹤0.01% |
614
-79,853
| -99% | -$659K |
2023 Q1
11 quarters
|
|
4880
Similarweb
SMWB
$702M
| $5.09K | ﹤0.01% |
679
+557
| +457% | +$4.49K |
2023 Q2
10 quarters
|
|
4881
Invesco S&P 500 BuyWrite ETF
PBP
$392M
| $5.07K | ﹤0.01% |
+222
| New | +$5.02K |
2025 Q4
0 quarters
|
|
4882
ADS-TEC Energy
ADSE
$796M
| $4.86K | ﹤0.01% |
383
-207
| -35% | -$2.33K |
2024 Q4
4 quarters
|
|
4883
ProShares Short 20+ Year Treasury ETF
TBF
$144M
| $4.82K | ﹤0.01% |
+200
| New | +$4.74K |
2025 Q4
0 quarters
|
|
|
ILLR
4884
Triller Group Inc
ILLR
$5.07M
| $4.8K | ﹤0.01% |
14,998
+450
| +3% | +$2.77K |
2025 Q2
2 quarters
|
|
4885
Mach Natural Resources
MNR
$1.72B
| $4.7K | ﹤0.01% |
426
-2,054
| -83% | -$24.6K |
2024 Q4
4 quarters
|
|
|
DECM
4886
FT Vest U.S. Equity Max Buffer ETF - December
DECM
$36M
| $4.7K | ﹤0.01% |
143
-4,465
| -97% | -$145K |
2025 Q1
3 quarters
|
|
|
PBT
4887
Permian Basin Royalty Trust
PBT
$1.47B
| $4.64K | ﹤0.01% |
+273
| New | +$4.89K |
2025 Q4
0 quarters
|
|
4888
Invesco Preferred ETF
PGX
$3.62B
| $4.61K | ﹤0.01% |
+410
| New | +$4.67K |
2025 Q4
0 quarters
|
|
4889
VanEck Africa Index ETF
AFK
$98.1M
| $4.41K | ﹤0.01% |
+165
| New | +$4.08K |
2025 Q4
0 quarters
|
|
|
DPRO
4890
Draganfly
DPRO
$207M
| $4.4K | ﹤0.01% |
+637
| New | +$5.38K |
2025 Q4
0 quarters
|
|
|
ZSPC
4891
DELISTED
ZSPACE INC NEW
ZSPC
| $4.35K | ﹤0.01% |
369
+105
| +40% | +$2K |
2025 Q1
3 quarters
|
|
|
SOUL.U
4892
Soulpower Acquisition Corp Units
SOUL.U
| $4.13K | ﹤0.01% |
+400
| New | +$4.16K |
2025 Q4
0 quarters
|
|
4893
Innovator US Equity Ultra Buffer ETF May
UMAY
$140M
| $4.02K | ﹤0.01% |
110
+54
| +96% | +$1.95K |
2024 Q3
5 quarters
|
|
4894
Innovator US Equity Ultra Buffer ETF January
UJAN
$255M
| $3.98K | ﹤0.01% |
92
-3,427
| -97% | -$146K |
2024 Q3
5 quarters
|
|
|
BCYC
4895
Bicycle Therapeutics
BCYC
$237M
| $3.98K | ﹤0.01% |
562
-1,710
| -75% | -$12.6K |
2023 Q1
11 quarters
|
|
4896
Rallybio
RLYB
$90.7M
| $3.92K | ﹤0.01% |
715
| – | – |
2022 Q1
15 quarters
|
|
4897
Ternium
TX
$11.1B
| $3.86K | ﹤0.01% |
101
-1,597
| -94% | -$58.7K |
2017 Q2
34 quarters
|
|
|
IRD
4898
Opus Genetics
IRD
$381M
| $3.82K | ﹤0.01% |
1,900
| – | – |
2025 Q1
3 quarters
|
|
|
CEW
4899
WisdomTree Emerging Currency Strategy Fund
CEW
$19.5M
| $3.78K | ﹤0.01% |
+200
| New | +$3.81K |
2025 Q4
0 quarters
|
|
|
IRBT
4900
DELISTED
iRobot
IRBT
| $3.67K | ﹤0.01% |
33,350
+33,059
| +11,360% | +$99.6K |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.